- Home
- ZURA vs CGC Comparison
ZURA vs CGC Comparison
Compare ZURA & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | CGC |
|---|---|---|
| Founded | 2022 | N/A |
| Country | United States | Canada |
| Employees | 30 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 435.0M | 404.3M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | ZURA | CGC |
|---|---|---|
| Price | $6.27 | $1.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $11.78 | N/A |
| AVG Volume (30 Days) | 457.9K | ★ 7.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.75 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | N/A | $8.04 |
| Revenue Next Year | N/A | $4.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $0.77 |
| 52 Week High | $7.25 | $2.38 |
Technical Indicators
Market Signals| Indicator | ZURA | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 38.48 |
| Support Level | $5.62 | $1.01 |
| Resistance Level | $6.90 | $1.24 |
| Average True Range (ATR) | 0.52 | 0.04 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 0.98 | 2.78 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.